Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production  by Sütő, Tamás et al.
Kidney International, Vol. 48 (1995), pp. 1272—1277
Acute changes in urinary excretion of nitrite + nitrate do not
necessarily predict renal vascular NO production
TAMAS SUTÔ,' GYORGY LOSONCZY, CHANGBIN Qiu, CHERYL HILL, LENNIE SAMSELL, JOHN RUBY,
NYLES CHARON, Rocco VENUTO, and CHRIS BAYLIS
Departments of Physiology and Microbiology/Immunology, West Virginia University, Robert C. Byrd Health Sciences Center, Moigantown, West Virginia,
USA; The Semmeiweis University Medical School, Pathophysiology Institute, Budapest, Hungaiy; and Department of Medicine, Division of Nephrology,
SUNY, Buffalo, New York, USA
Acute changes in urinary excretion of nitrite + nitrate do not neces-
sarily predict renal vascular NO production. NO2 + NO3 (NO), the
stable oxidation products of NO, and cGMP are widely accepted as indices
of in vivo NO production. Whether acute changes in urinary excretion of
nitrite + nitrate (UNOXV) can be taken to reflect acute changes in renal
and/or systemic NO production is not known. The present studies were
conducted in the conscious rat to investigate the effect on acute changes in
UNoV, of maneuvers that (a) enhance NO production and (b) act as
diuretics. L-arginine (L-arg) and acetyicholine (Ach) produce equivalent
NO dependent falls in renal vascular resistance (RVR), but a much
greater increase in UNOX V is seen with L-arg. D-arg does not stimulate
NO and has no renal vasodilatory effect, but produces a large rise in
UNOXV, and SNP lowers BP but not RVR and results in a reduced
UN0XV. None of the diuretics employed should stimulate the NO system
or lower RVR; however, the proximally acting agents, acetazolamide and
D-arg increased UN0XV, while the loop diuretic furosemide had little
effect. H20 diuresis (a distal event) led to a fall in UNOXV. These data
suggest that NO is reabsorbed extensively in the proximal tubule and that
inhibition of proximal reabsorption leads to an increase in UNOXV. Also,
our results show that the relationship between UNOXV and UCOMPV is
unpredictable. Therefore, we conclude that measurements of acute
changes in UNOXV and/or UCGMPV should be interpreted cautiously, since
they may reflect altered tubular handling of NO,, rather than the acute
activity of the systemic and/or renal NO systems.
Many types of mammalian cells have the ability to make nitric
oxide (NO) [1, 21. In the basal state, in the absence of immune
stimulation, vascular endothelial cells and the nervous system
probably provide the bulk of NO synthesized within the body,
although transporting epithelia also make some constitutively
formed NO [1—3]. NO is enzymatically produced from L-arginine
and acts on blood vessels to produce a relaxation, via cGMP
production. In the presence of NO, blood pressure (BP) and renal
vascular resistance (RVR) are lower than in NO deficient states
[1, 4]. The in vivo activity of NO cannot be directly monitored
because NO is very unstable, rapidly undergoing oxidation initially
to nitrite (NO2) and ultimately to the stable endproduct, nitrate
(NO3) (NO2 + NO3 = NOR) [1]. The amount of NO produced
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by the body should therefore provide an index of NO production,
when dietary NO intake has been accounted for.
Many groups, including our own, have begun to use the 24
hours urinary NO,, excretion (UNOXV) as a measure of peripheral
and renal vascular NO production. It is also possible that acute
changes in NO production may be reflected by acute changes in
UNOXV. However, recent studies from our laboratory have cast
doubt on this latter assumption since in the anesthetized rat,
UNOXV actually increases during administration of the NO syn-
thesis inhibitor, nitro-L-arginine methyl ester (NAME) [5]. In
order to interpret acute urinary excretion data, it is necessary to
understand how a substance is handled within the renal tubule,
and there is a paucity of information on the tubular handling of
NOR.
Accordingly, the present studies were undertaken to investigate
how well acute changes in UNOXV reflect alterations in RVR,
known to be caused by altered renal NO production. The pre-
dicted relationship would be for UN0XV to correlate inversely
with RVR. These experiments were conducted in the normal
conscious chronically catheterized rat studied in the basal state
and during acute maneuvers to alter renal function. The first
studies involved manipulation of the NO system; subsequently we
conducted additional experiments to alter tubular function inde-
pendent of the NO system, by administration of diuretics.
Methods
Studies were conducted on 31 male (aged 3 to 5 months)
Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN,
USA). Rats were allowed ad libitum access to drinking water and
a diet containing approximately 24% protein, 0.5% sodium and
263 nmol/g NOR. Catheters were placed in the urinary bladder
(via a suprapubic midline incision) and in the left femoral artery
and vein and threaded up to the aorta and vena cava. The vascular
catheters were exteriorized at the back of the neck and primed
with a 50% dextrose/1000 IU heparin (1:1) solution and plugged.
The urinary bladder was flushed with a neomycin solution and
also plugged so that the animal could void normally through the
urethra. This catheterization was carried out under general anes-
thesia and using full sterile conditions, and details have been given
earlier [4]. Rats were housed individually after catheterization and
were allowed at least seven days before any experiments were
conducted to measure renal hemodynamics in the awake state.
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Also, before renal hemodynamic experiments, all rats were exten-
sively handled and trained to accept the noises in the laboratory
and the restraining cage. Several experiments were conducted on
each rat. A rest period of at least two days was allowed between
experiments.
During renal function experiments rats were placed in a re-
straining cage and an i.v. infusion of 0.9% NaCI containing
tritiated inulin (2 to 5 xCIml) and para-amino hippuric acid
(PAH, 1%) was given at the nonexpanding infusion rate of 50
jxl/min/kg body wt for an 80-minute equilibration period and then
throughout the control period. During this equilibration the
arterial line was connected to a pressure transducer for monitor-
ing of arterial BP, and the bladder catheter was opened and
connected to a tube with a sidearm to allow collection of urine.
Periodically, the bladder was inflated with air to assist in collection
of all bladder urine. At the end of the 80-minute equilibration
period, two control, 20-minute urine collections were made with
midpoint arterial blood samples. After centrifugation and removal
of plasma for later analysis, red blood cells were reconstituted
with an equal volume of sterile saline and returned to the rat.
After completion of control measurements one of the following
series of experiments were conducted.
Group 1 rats (N = 5) received L-arginine (L-arg), the endog-
enous substrate for NO synthesis. Rats initially received a bolus
(300 mg/kg) of L-arginine followed by a continual infusion at 50
mg/kg/mm, as described by us previously [4]. The L-arginine was
dissolved in the inulin + PAH solution and given at 50 itI/kg/min
as in control. After 60 minutes, two further 20-minute clearance
measurements were made during which the L-arginine infusion
was continued. In Group 2 animals (N = 5) a similar experimental
protocol was adopted with the exception that D-arginine instead
of L-arginine was used. In Group 3 experiments (N = 7) the
infusate was changed to one containing acetyicholine (Ach) to
deliver a dose of 10 jxg/kg/min and after 10 minutes of equilibra-
tion, two further clearance periods were measured. In Group 4
experiments (N = 5), the endothelium-independent nitrodilator
sodium nitroprusside (SNP) was added to the infusate to deliver
a dose of SNP of 10 jig/kg/mm. Groups 1, 3 and 4 experiments
involved manipulation of NO production and renal vascular
resistance while Group 2 rats were controls, in which the inert
stereoisomer of the NO substrate (D-Arg) was given.
In Groups 2, 5, 6 and 7, urine flow (V) was manipulated
independently of the NO system, to investigate the role of V as a
determinant of UNOXV. Group 2 rats, described above, received
D-arg which functions as a proximally acting osmotic diuretic.
Group 5 rats (N = 7) received an i.v. bolus of 50 mg/kg
acetazolamide followed by a maintenance infusion of 0.83 mg/kg!
mm; the diuretic effects of this dose have previously been de-
scribed [6]. Acetazolamide was initially dissolved in 1 N NaOH
(111 mg/ml) and then diluted in the infusate to a final concentra-
tion of 3.33 mg!ml. The infusate itself was diluted five times the
original concentration (used in control) with a solution containing
275 mmol/liter NaHCO3 and 25 mmol/liter KCI to replace urinary
losses of bicarbonate, as recommended previously [6]. The infu-
sion rate was increased by fivefold to compensate for the increase
in V. Ten minutes after the administration of the acetazolamide
bolus, two 20-minute clearance periods were measured. Group 6
rats (N = 5) received i.v. furosemide (1 mg/kg) as a bolus
injection. The infusate was then diluted 1 in 5 to I in 20 times with
sterile isotonic saline and the infusion rate increased by 5 to 20 X.
Ten minutes after the bolus of furosemide, two further 20-minute
clearance periods were measured. In Group 7 (N = 6), rats were
put into a maximal water diuresis after completion of control
measurements. An i.v. bolus was given of the arginine vasopressin
V2 receptor antagonist ([d(CH2)5,D-Ile2, lle4,Arg8]-vasopressin)
which selectively blocks the hydroosmotic action of AVP [7] in a
dose of 7 jig/kg body wt. Immediately after administration of the
AVP V2 antagonist the infusate was changed to a 5% dextrose
solution (1 ml/kglmin) containing inulin and PAH. After five
minutes of equilibration, two further urine clearance periods were
measured. In Groups 5, 6 and 7 where the infusate was diluted in
the experimental periods, the same quantity of inulin and PAH!
mm was delivered, as in control, and the increased fluid delivery
to the animal compensated for the diuretic effect and prevented
volume contraction, thus ensuring a sustained diuresis. The
primary goal of Groups 5 to 7 was to achieve similar elevations in
V to those seen in Groups 1 and 2.
At the end of all experimental periods in Group 1 to 7 rats, red
blood cells were reconstituted with 0.9% sterile isotonic saline and
restored to the animal. The volume of urine was measured
gravimetrically and urine was analyzed for tritiated inulin activity,
PAH, sodium and potassium concentration, and NO concentra-
tion. In Groups 1, 2, 5, 6, and 7, urinary cGMP concentration was
also measured. Arterial blood samples were analyzed for he-
matrocrit (hct), tritiated inulin activity and PAH and sodium
concentrations. Tritiated inulin was measured in 10 pA samples of
urine and plasma in a scintillation counter. PAH concentration
was measured colorimetrically [8]. Sodium concentration was
measured by flame photometry, urinary NO concentration was
measured by reduction of urinary NO3 to NO2 with the nitrate
reductase enzyme. This enzyme was produced by E. coli (ATCC
25922) grown in an anaerobic incubator and in a nitrate reduc-
tase-inducing medium for 14 hours. The enzyme was stored at
—70°C until used for the assay. In this assay the NO2 generated
from NO3 by the nitrate reductase enzyme, and any NO2 in the
urine, was detected and quantitated by the Griess reaction [9].
Briefly, 125 pi urine samples (diluted 3 to 4 X) were incubated
with 100 pA buffer (1.0 M HEPES, 2.4 mivi ammonium formate, pH
7.2) and 25 pA nitrate reductase enzyme (100 mg/ml), for one hour
at 37°C in a shaking water bath. The tubes were spun at 2000 g for
10 minutes, and the 100 pA of the supernatant was mixed with 150
j.d Griess reagent in 96 well plates and read at 543 nm in an
ELISA plate reader. NO2 standards were run in the range of 5 to
500 mM as well as a 100 mrvi NO3 standard, to test for complete
reduction by the enzyme. Cyclic GMP was measured by radioim-
munoassay using a competitive enzyme immunoassay (Cayman
Chemical Co, Ann Arbor, MI, USA). Samples were stored frozen
until the day of assay. All samples were run in duplicate or
triplicate and were diluted to the mid-range of the assay curve.
The intra- and interassay coefficients of variation 10%.
These measurements allow the calculation of GFR from inulin
clearance and renal plasma flow (RPF) from the PAH clearance,
factored for the renal extraction on PAH = 0.85 [10]. The renal
vascular resistance (RVR) was calculated as RVR = (BP-5)/RBF,
where RBF (renal blood flow) = RPF/1 — hct and 5 (mm Hg) is
the estimated pressure in the renal vein. The urinary excretions of
sodium, NO and cGMP were calculated from the respective
urine concentrations and V. Data are expressed throughout as
mean SE and statistical significance is assumed where P <0.05
using paired 1-test, one way ANOVA and regression analysis.
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Table 1. Summary of renal responses to manipulation of the NO system
Results
As shown in Tables 1 and 2, the baseline values of BP and renal
function were generally similar in all seven Groups. All rats were
on a similar diet and studied under similar conditions, and there
were no statistically significant differences between control values
of either UN0XV or UCGMPV between any groups.
Group 1 (body wt 423 11 g) received L-arg, which had no
effect on BP or hct but produced a renal vasodilation leading to a
rise in RPF and a nonsignificant increase in GFR (Table 1). A
marked natriuretic and diuretic response occurred (> 10 X
increase) and a substantial kaliuresis was also seen with L-arg.
The increased UNaV was entirely due to the large increase in
FENa, since filtered Na was unchanged, due to constancy of GFR
and plasma Na. In response to L-arg infusion, a substantial rise
occurred in UNOXV but UCGMPV did not increase. Group 2 (body
wt = 394 12 g) received D-arg, which unexpectedly produced an
increase in BP but had no effect on renal hemodynamies, since
D-arg is not a substrate for NO production. Significant diuretic,
natriuretie and kaliuretic responses occurred as well as an in-
creased FENa with D-arg. A large rise also occurred in UNOXV
although again, UCGMPV did not increase (Table 1). Group 3
(body wt 386 16 g) received Ach which produced the expected
fall in BP and renal vasodilation, leading to an increased RPF but
no change in GFR, In contrast to Groups I and 2, Ach produced
a small rise in UNaV and FENa, and no change in V or UKV. An
increase in UNOXV was seen with Ach but this was smaller in
magnitude than that observed with L-arg, despite a similar
reduction in RVR (Fig. 1). In Group 4 rats (body wt 379 15 g),
SNP produced a marked fall in BP but no change in RVR, and
both RPF and GFR fell. Falls occurred in V and UKV with no
change in UNaV or FENa. In this group, UNOXY fell with SNP
(Table 1, Fig. 1). Measurements were not made of UGMpV in
either Groups 3 or 4. As shown in Figure 1, in Groups I to 4, the
response of UNOXY correlated better with V than with 1/RVR.
In the second series of experiments, the effect of various
diuretics was investigated. The response to the proximally acting,
osmotic diuretic D-arg (Group 2) has been discussed above.
Group 5 rats (body wt 374 6 g) received acetazolamide (acet)
which also acted in the proximal tubule. Acet produced a small
rise in BP, no change in renal hemodynamics and a marked
natriuretic, diuretic and kaliuretic response. In this group UNQXV
increased with acet, whereas UCGMPV fell (Table 2, Fig. 2). Group
BP
mm Hg
hct
vol%
GFR RPF RVR
mm Hg!
ml!min
-
V
p.1!minml!min
Group 1, L-ARG
controlX 5E 117 3 43 1 2.71 0.16 10.0 6.4 0.1 18 1
expX±sE 121±5 42±1 3.17±0.33 16.7±1.2 41±0.2 268±9
F, c vs. exp NS NS NS <0.005 <0.005 <0.001
Group 2, D-ARG
controlX±sE 117±2 43±1 2.85±034 12.9±1.2 5.2±0.5 22±4
expX±su 128±2 44±1 2.96±0.23 14.3±2.5 5.5±0.9 229±29
c vs. exp <0.005 NS NS NS NS <0.005
Group 3, ACH
controlX±se 115±3 43±1 2.63±0.13 11.8±0.8 5.5±0.4 13±2
expX±sE 107±4 42±1 2.51±0.07 15.1±1.4 4.2±0.6 16±2
P, c vs. exp <0.005 NS NS <0.05 <0.005 NS
Group 4, SNP
controlX±sE 115±4 42±1 2.80±0.15 12.5±0.7 5.2±03 25±6
expX SE 99±4 40±1 213±0.08 9.0± LU 6.6±0.7 15±4
F, c vs. exp <0.01 <0.01 <0.05 <0.01 NS <0.05
Table 1. Continued
UaaV UKV flNa
mEq!liter
LLNa
%
IT ITNOX
nmol!min
IT
cOMP
pmol!minp.Eq!min
Group 1, L-ARG
control X SE 2.2 0.2 2.3 0.3 140 3 0.58 0.06 4.75 1.14
exp X SE 28.8 1.7 9.1 0.8 136 2 6.78 0.40 18.18 3.72
F, c vs. cxp <0.001 <0.001 NS <0.001 <0.01
Group 2, D-ARG
control X SE 2.0 0.5 2.3 0.4 141 2 0.51 0.13 4.94 1.03
exp X SE 19.8 3.9 5.4 0.3 139 2 4.84 0.94 12.64 1.28
F, c vs. exp <0.005 <0.01 NS <0.01 <0.001
Group 3, ACH
control X SE 1.9 0.3 2.0 0.2 142 1 0.49 0.07 3.71 0.72
exp X SE 2.6 0.3 2.0 0.1 142 1 0.72 0.07 5.97 0.80
F, c vs. exp <0.05 NS NS <0.01 <0.05
Group 4, SNP
control X SE 1.9 0.4 2.8 0.2 141 1 0.50 0.11 4.95 0.67
exp X SE 0.9 0.1 1.7 03 141 1 0.29 0.05 1.64 0.17
F, c vs. cxp NS <0.05 NS NS <0.01
28 8
63 28
NS
46 15
130 68
NS
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Table 2. Summaiy of renal responses to manipulation of tubular reabsorption
BP
mm Hg
hct
vol%
GFR RPF RVR
mm Hg!
mi/mm
.V
p1/mmmi/mm
Group 2, D-ARG
control X SE 117 2 43 1 2.85 0.34 12.9 1.2 5.2 0.5 22 4
exp X SE 128 2 44 1 2.96 0.23 14.3 2.5 5.5 0.9 229 29
P, c vs. exp <0.005 NS NS NS NS <0.005
Group 5, ACET
control X SE 118 2 43 1 2.85 0.11 10.7 0.4 6.1 0.2 15 2
exp 2 X SE 123 2 43 1 2.57 0.17 10.8 0.5 6.3 0.3 191 12
P, c vs. exp <0.05 NS NS NS NS <0.005
Group 6, furosemide
control X SE 117 3 43 1 2.78 0.13 11.7 0.5 5.5 0.3 18 2
exp 2 X SE 122 3 44 1 2.53 0.17 9.6 0.3 6.9 0.4 305 44
P, c vs. exp <0.05 <0.05 <0.05 <0.001 <0.005 <0.001
Group 7, H20 diuresis
control X SE 119 3 44 1 2.74 0.24 12.3 1.1 5.5 0.6 14 2
exp 1 X SE 127 2 44 1 3.08 0.21 8.0 0.6 8.5 0.5 240 46
P, c vs. exp <0.001 NS NS <0.05 <0.005 <0.005
Table 2. Continued
UNaV UKV DNa
mEqiliter
17E?Na
%
T I JNOX
nmol/min
I I
cOMP
pmoi/minp.Eq/min
Group 2, D-ARG
control X SE 2.0 0.5 2.3 0.4 141 2 0.51 0.13 4.94 1.03 46 15
exp X SE 19.8 3.9 5.4 0.3 139 2 4.84 0.94 12.64 1.28 130 68
P, c vs. exp <0.005 <0.01 NS <0.01 <0.001 NS
Group 5, ACET
control X SE 1.6 0.2 2.1 0.1 141 2 0.41 0.05 3.06 0.73 63 9
exp 2X SE 30.3 1.8 7.2 0.2 144 1 8.45 0.71 8.72 1.15 15±4
P, c vs. exp <0.001 <0.001 <0.01 <0.001 <0.001 <0.005
Group 6, furosemide
control X SE 1.7 0.3 2.4 0.3 140 1 0.42 0.06 3.94 0.85 38 6
exp2X SE 25.3 4.9 6.5 1.3 141 1 6.70 0.88 6.58 1.75 84±23
P, c vs. exp <0.05 NS <0.001 NS NS <0.05
Group 7, H20 diuresis
control X SE 2.3 0.3 2.4 0.3 138 1 0.59 0.03 3.80 0.72 30 3
exp 1 X SE 4.6 1.0 4.6 1.2 137 1 0.99 0.17 2.36 0.96 47 8
P,c vs. exp <0.05 NS <0.05 <0.05 <0.05 NS
6 rats (body wt 399 9 g) received furosemide (furo) which
produced a small rise in BP and renal vasoconstriction, resulting
in falls in RPF and GFR. Marked natriuretic, diuretic and
kaliuretic responses occurred and in this group there was little
change in UNOXV but UCGMPV increased. In Group 7 (body wt
400 12 g), a water diuresis was produced, which was associated
with an increase in BP, renal vasoconstriction and a fall in RPF
with no change in GFR. In this group a marked diuresis was seen
as well as a small increase in UNaV, but no change in UKV. A fall
in UN0xV occurred without a change in UCGMEV (Table 2, Fig.
2). As shown in Figure 2 there was no relationship between
UNOXV and 1/RVR in Groups 2, 5, 6 and 7, and the relationship
between V and UNOXV was only evident for Groups 2 and 5; rats
who received proximally acting diuretics.
Overall, L-arg, D-arg and acet had similar effects on UNOXV,
whereas agents which produced similar levels of renal vasodilation
by an NO-dependent mechanism (L-arg and Ach) did not show
UCGMPV from all experiments in which both variables were mea-
sured. There is clearly no overall relationship between UNOXV and
UCGMPV.
Discussion
We initially set out to investigate the relationship between
UNOXV and tone in the renal vasculature, using a range of
vasodilators. L-arg acts preferentially on the kidney to cause a
vasodilation via increased NO production [4], either by providing
limited substrate or by competing with local L-arg analogs which
function as competitive inhibitors of NO synthesis [11]. In the
present study, L-arg led to selective renal vasodilation, presum-
ably largely NO mediated, as well as a large increase in UNOXV.
This follows the predicted relationship between RVR and UN0XV.
This prediction breaks down, however, in the following Groups;
rats receiving the inactive D-arg [1] have no renal vasodilatory
response but do exhibit a large rise in UN0,(V. In contrast, rats
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the periphery; nevertheless, rats receiving Ach exhibited a much
smaller rise in UNOXV versus rats given L-arg. The drug SNP
produces widespread vasodilation by functioning as an NO donor
[13]. In our studies a marked fall in BP occurred with SNP but
RVR did not change significantly, which led to falls in RPF, GFR
and V. UNOXV also fell, despite the marked depressor response
due to NO generation. Thus, in this first series of experiments
UNOXV did not always change as predicted when activation of the
NO system led to renal and/or systemic vasodilation. Rather than
correlating inversely with RVR, the better correlation with
UNOXY was a direct relationship with V, reminiscent of the PG
system, where V influences PG excretion [14].
The second series of experiments were designed to further
investigate the relationship between V and UNOXV. D-arg, the
inert isomer which is not a substrate for NO synthesis [1],
functions as a diuretic by virtue of its osmotic action in the
proximal tubule [15]. With this agent a large increase in UNOXV
correlated well with increased V. Acetazolamide also functions as
a proximally acting diuretic but works via a different mechanism
involving inhibition of the Na-H exchanger [6]. With this
maneuver UNOXV correlated also well with V. In contrast,
furosemide acts as a diuretic mainly on the thick ascending limb of
the loop of Henle [15] and a water diuresis is an event in which
reabsorption is inhibited in the collecting duct [16]. Despite the
Fig. 2. Summaty of the responses of renal vascular resistance (RI/I?), urinaty
NO2 + NO3 (= NON) excretion (UN0XV) and urine flow (V), to iv.
D-arginine, Group 2 (D-A,g) and acetazolamide, Group 5 (Acet), both
proximally acting diuretics; to furosemide, Group 6 (furo) which acts
primarily on the loop of Henle; and a water diuresis, Group 7, which is an
event occuning in the collecting duct. Data are shown as % change from the
control value.
fact that both furosemide and the water diuresis produce similar
increases in V as acet and D-arg, these diuretic effects, which act
downstream from the proximal tubule are not associated with
increases in UNOXV; in fact with the water diuresis, UNOXV falls.
These data provide indirect evidence suggesting that NO is
extensively reabsorbed normally in the proximal tubule, and that
inhibition of proximal reabsorption therefore leads to a large
increase in UNOXV. We did not measure plasma NOx levels in
the present study; however, other workers have reported values of
plasma NO for normal rats from 40 gmol/liter on low NO3
intake [17] to —450 to 200 xmol/liter in rats on normal chow [18,
19]. Bank and Aynedjian have reported that in the normal rat,
FENOX is -44% [19] and taking the highest value of plasma NO
(200 Mmol/liter), and assuming that all this plasma NO is freely
filterable, we also calculate that our estimated FENOX is —15 to
20% in the control, baseline state in the present experiments; thus
NO is extensively reabsorbed in the tubule under normal condi-
tions. There is no micropunture or isolated perfused tubule data
on tubular NO handling which could give insight into the
segmental handling of filtered NOR, but our whole kidney data
certainly supports the notion that the proximal tubule extensively
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Fig. 3. Regression analysis of the relationship between UNOXV and UGMPV
in rats before and during D-arg, Group 2 (0), L-arg, Group 1 (•), water
diuresis, Group 7 (LI), acet, Group 5 () andfuro, Group 6 (Y). There was
clearly no overall correlation between UNOXV and UoMpV (r = 0.07, p =
NS).
reabsorbs filtered NON. In addition to tubular handling of filtered
NOR, there is also the likelihood that NO generated by the
tubular epithelial cells contributes to UNOXV [3, 20]. Thus,
measurement of acute UNOXV during maneuvers that affect renal
function, cannot be relied upon to provide an assessment of acute
changes in systemic and/or renal NO generation.
To further "muddy the waters," the relationship between
UNOXV and UCGMPV, the second messenger of NO is also
unpredictable. It is recognized that other hormones such as atrial
natriuretic peptide also use cGMP as a second messenger [21],
thus UCGMPV will not directly correlate with NO production.
However, the renal handling of cGMP is also quite different to
that of NO and as reported by Conrad and Vernier [22], FECGMP
is 100% in the control, baseline state. Any situation in which
tubular reabsorption is altered will probably alter the relationship
between UNOXV and UCGMPV and as shown in Figure 3 there is
no correlation between these variables under the conditions of the
experiments described here.
Regrettably, it seems that UNOXV and/or UCGMPV measure-
ments cannot reliably provide insight into the acute activity of the
systemic and/or renal NO systems. The 24-hour UNQXV and
UCGMPV values probably do reflect production rates [17, 22].
However, in the case of UNQXV, interpretations remain complex
since dietary intake of NO is variable and contributes to UNOXV,
although only 50% of ingested NO is excreted in the urine, the
remainder is lost via the feces and metabolized [23, 24].
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